Secondary Mesenteric Panniculitis as a Paraneoplastic Syndrome: An Updated Review

Mónica García-Fernández; María Dolores Jover-Ríos; Pedro Esteve-Atiénzar; Juan Méndez-Mora; Alex Méndez-Jover; Sonia Cascant-Pérez; Francisco Caparrós-Hernández; Carmen Seguí-Pérez; Marc Seguí-Pérez; Lidia Ramírez-Utrero; Carles García-Cervera; Juan Manuel Núñez-Cruz; David Bonet-Tur; Sara Bañón-Escandell; Pablo Roig-Rico; Jorge Peris-García; Asunción Pérez-Fullana; José Miguel Seguí-Ripoll

doi:doi:10.11648/j.ajim.20190706.11

Secondary Mesenteric Panniculitis as a Paraneoplastic Syndrome: An Updated Review

Mónica García-Fernández, María Dolores Jover-Ríos, Pedro Esteve-Atiénzar, Juan Méndez-Mora, Alex Méndez-Jover, Sonia Cascant-Pérez, Francisco Caparrós-Hernández, Carmen Seguí-Pérez, Marc Seguí-Pérez, Lidia Ramírez-Utrero, Carles García-Cervera, Juan Manuel Núñez-Cruz, David Bonet-Tur, Sara Bañón-Escandell, Pablo Roig-Rico, Jorge Peris-García, Asunción Pérez-Fullana, José Miguel Seguí-Ripoll

Published in American Journal of Internal Medicine (Volume 7, Issue 6)

Received: 12 August 2019 Accepted: 6 September 2019 Published: 24 October 2019

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

In response to the case of a patient with mesenteric panniculitis (MP) and proliferative disease, we reviewed the literature on their possible association and associations with other neoplasms. MP is a non-specific chronic inflammation of the mesenteric fat, with low prevalence and unknown etiology; patients may be asymptomatic or present predominantly gastrointestinal complaints. The disease can be either primary or secondary to other pathologies, including neoplastic ones. Diagnosis is made via computed tomography (CT) and confirmed by biopsy. Currently, there is no established treatment for MP. The literature contains series of variable sample sizes, case reports, reviews of other published studies, and some series after a 5-year follow-up. Papers tend to be relatively consistent when it comes to prevalence data and clinical manifestations. However, there is still controversy regarding the role that secondary MP could play in a paraneoplastic picture. From the diagnostic point of view, the incorporation and use of positron emission tomography (PET), together with CT, has been helpful for the approach and the diagnostic focus in this field. Nevertheless, its usage and the discrimination cut point between inflammatory pathology and tumor pathology (maximum standard uptake value: SUVmax) are not clearly defined in neoplastic cases.

Published in	American Journal of Internal Medicine (Volume 7, Issue 6)
DOI	10.11648/j.ajim.20190706.11
Page(s)	141-146
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2019. Published by Science Publishing Group

Keywords

Mesenteric Panniculitis, Abdominal Mass, Paraneoplastic Phenomenon, CT, PET/CT

References

[1]	Ayala Gutiérrez MM, Ramón Garrido E. Paniculitis Mesentérica. Revisión. Med Clin (Barc). 2016; 146 (11): 497–505.
[2]	Jura V. Sclerosing and retractile mesenteritis. Policlinica. 1924; 31: 575–581.
[3]	Ogden WW, 2nd, Bradburn DM, Rives JD. Mesenteric Panniculitis: Review of 27 Cases. Ann Surg. 1965; 161: 864-875.
[4]	Scheer F et al. Mesenteric Panniculitis (MP) in CT – A Predictor of Malignancy? Fortschr Röntgenstr. 2016; 188: 926-932.
[5]	Mejías Manzano MA et al. Mesenteritis esclerosante relacionada con IgG4, una entidad rara causante de dolor abdominal. Rev Esp Enferm Dig. 2018; 110 (3): 201-203.
[6]	Patlas M et al. Cross-Sectional Imaging of Nontraumatic Peritoneal and Mesenteric Emergencies. Canadian Association of Radiologists Journal 2013; 64: 148-153.
[7]	Klasen J. et al. Treatment options for spontaneous and postoperative sclerosing mesenteritis. World Journal of Gastrointest Surgery. 2016; 8 (11): 761-765.
[8]	He H. et al. Sclerosing Mesenteritis: Multidisciplinary Collaboration Is Essential for Diagnosis and Treatment. Gastroenterol Res. 2017; 10 (1): 50-55.
[9]	Gögebakan Ö, Osterhoff MA, Albrecht T. Mesenteric Panniculitis (MP): A Frequent Coincidental CT Finding of Debatable Clinical Significance. Fortschr Röntgenstr 2018; 190: 1044-1052.
[10]	Kipfer RE, Moertel CG, Dahlin DC. Mesenteric lipodystrophy. Annals of internal medicine 1974; 80: 582-588.
[11]	Daskalogiannaki M, Voloudaki A, Prassopoulos P. et al. CT evaluation of mesenteric panniculitis: prevalence and associated diseases. American journal of roentgenology 2000; 174: 427-431.
[12]	Canyigit M, Koksal A, Akgoz A. et al. Multidetector-row computed tomography findings of sclerosing mesenteritis with associated diseases and its prevalence. Japanese journal of radiology 2011; 29: 495-502.
[13]	Wilkes A, Griffin N, Dixon L. et al. Mesenteric panniculitis: a paraneoplastic phenomenon? Diseases of the colon and rectum 2012; 55: 806-809.
[14]	Cross AJ, McCormick JJ, Griffin N. et al. Malignancy and mesenteric panniculitis. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland 2016; 18 (4): 372-377.
[15]	Halligan S, Plumb A, Taylor S. Mesenteric panniculitis: systematic review of cross-sectional imaging findings and risk of subsequent malignancy. Eur Radiol 2016; 26 (12): 4531–4537.
[16]	Gogebakan O, Albrecht T, Osterhoff MA. et al. Is mesenteric panniculitis truely a paraneoplastic phenomenon? A matched pair analysis. European journal of radiology 2013; 82: 1853-1859.
[17]	Van Putte-Katier N, van Bommel EF, Elgersma OE. et al. Mesenteric panniculitis: prevalence, clinicoradiological presentation and 5-year follow-up. The British journal of radiology 2014; 87 (1044): 20140451.
[18]	Protin-Catteau L, Thiefin G, Barbe C. et al. Mesenteric panniculitis: review of consecutive abdominal MDCT examinations with a matched-pair analysis. Acta radiologica 2016; 57: 1438-1444.
[19]	Khasminsky V, Ram E, Atar E. et al. Is there an association between mesenteric panniculitis and lymphoma? A case control analysis. Clin Radiol 2017; 72 (10): 844-849.
[20]	Coulier B. Mesenteric panniculitis. Part 2: prevalence and natural course: MDCT prospective study. JBR-BTR: organe de la Societe royale belge de radiologie 2011; 94: 241-246.
[21]	Orcajo Rincón, J., Rotger Regi, A., Mari Hualde, A., Reguera Berenguer, L., Hernandez Moreno, L. y Alonso Farto, J. A prospective study to determine the real value of mesenteric 18F-FDG uptake in cancer patients. inflammatory or tumoral mesenteric paniculitis? Rev Esp Med Nucl Imagen Mol. 2014; 33 (6): 352-357.
[22]	Zissin R, Metser U, Hain D, Even-Sapir E. Mesenteric panniculitis in oncologic patients: PET-CT findings. Br J Radiol. 2006; 79: 37-43.
[23]	Ehrenpreis E, Rao AS, Aki R, Brown H, Pae T, Boiskin I. Normal positron emission tomography-computerized tomogram in a patient with apparent mesenteric panniculitis: biopsy is still the answer. Case Rep Gastroenterol. 2009; 3: 131-7.
[24]	M. Mella-Laborde, F. Ivorra-Muñoz, S. García-García, J. M. Seguí-Ripoll, A. Compañ-Rosique. Paniculitis mesentérica como manifestación inicial de un linfoma de células B. Acta Gastroenterol Latinoam 2015: 45 (2) 001-002.

Cite This Article

Plain Text BibTeX RIS

APA Style

Mónica García-Fernández, María Dolores Jover-Ríos, Pedro Esteve-Atiénzar, Juan Méndez-Mora, Alex Méndez-Jover, et al. (2019). Secondary Mesenteric Panniculitis as a Paraneoplastic Syndrome: An Updated Review. American Journal of Internal Medicine, 7(6), 141-146. https://doi.org/10.11648/j.ajim.20190706.11

Copy | Download

ACS Style

Mónica García-Fernández; María Dolores Jover-Ríos; Pedro Esteve-Atiénzar; Juan Méndez-Mora; Alex Méndez-Jover, et al. Secondary Mesenteric Panniculitis as a Paraneoplastic Syndrome: An Updated Review. Am. J. Intern. Med. 2019, 7(6), 141-146. doi: 10.11648/j.ajim.20190706.11

Copy | Download

AMA Style

Mónica García-Fernández, María Dolores Jover-Ríos, Pedro Esteve-Atiénzar, Juan Méndez-Mora, Alex Méndez-Jover, et al. Secondary Mesenteric Panniculitis as a Paraneoplastic Syndrome: An Updated Review. Am J Intern Med. 2019;7(6):141-146. doi: 10.11648/j.ajim.20190706.11

Copy | Download

@article{10.11648/j.ajim.20190706.11,
  author = {Mónica García-Fernández and María Dolores Jover-Ríos and Pedro Esteve-Atiénzar and Juan Méndez-Mora and Alex Méndez-Jover and Sonia Cascant-Pérez and Francisco Caparrós-Hernández and Carmen Seguí-Pérez and Marc Seguí-Pérez and Lidia Ramírez-Utrero and Carles García-Cervera and Juan Manuel Núñez-Cruz and David Bonet-Tur and Sara Bañón-Escandell and Pablo Roig-Rico and Jorge Peris-García and Asunción Pérez-Fullana and José Miguel Seguí-Ripoll},
  title = {Secondary Mesenteric Panniculitis as a Paraneoplastic Syndrome: An Updated Review},
  journal = {American Journal of Internal Medicine},
  volume = {7},
  number = {6},
  pages = {141-146},
  doi = {10.11648/j.ajim.20190706.11},
  url = {https://doi.org/10.11648/j.ajim.20190706.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20190706.11},
  abstract = {In response to the case of a patient with mesenteric panniculitis (MP) and proliferative disease, we reviewed the literature on their possible association and associations with other neoplasms. MP is a non-specific chronic inflammation of the mesenteric fat, with low prevalence and unknown etiology; patients may be asymptomatic or present predominantly gastrointestinal complaints. The disease can be either primary or secondary to other pathologies, including neoplastic ones. Diagnosis is made via computed tomography (CT) and confirmed by biopsy. Currently, there is no established treatment for MP. The literature contains series of variable sample sizes, case reports, reviews of other published studies, and some series after a 5-year follow-up. Papers tend to be relatively consistent when it comes to prevalence data and clinical manifestations. However, there is still controversy regarding the role that secondary MP could play in a paraneoplastic picture. From the diagnostic point of view, the incorporation and use of positron emission tomography (PET), together with CT, has been helpful for the approach and the diagnostic focus in this field. Nevertheless, its usage and the discrimination cut point between inflammatory pathology and tumor pathology (maximum standard uptake value: SUVmax) are not clearly defined in neoplastic cases.},
 year = {2019}
}

Copy | Download

TY  - JOUR
T1  - Secondary Mesenteric Panniculitis as a Paraneoplastic Syndrome: An Updated Review
AU  - Mónica García-Fernández
AU  - María Dolores Jover-Ríos
AU  - Pedro Esteve-Atiénzar
AU  - Juan Méndez-Mora
AU  - Alex Méndez-Jover
AU  - Sonia Cascant-Pérez
AU  - Francisco Caparrós-Hernández
AU  - Carmen Seguí-Pérez
AU  - Marc Seguí-Pérez
AU  - Lidia Ramírez-Utrero
AU  - Carles García-Cervera
AU  - Juan Manuel Núñez-Cruz
AU  - David Bonet-Tur
AU  - Sara Bañón-Escandell
AU  - Pablo Roig-Rico
AU  - Jorge Peris-García
AU  - Asunción Pérez-Fullana
AU  - José Miguel Seguí-Ripoll
Y1  - 2019/10/24
PY  - 2019
N1  - https://doi.org/10.11648/j.ajim.20190706.11
DO  - 10.11648/j.ajim.20190706.11
T2  - American Journal of Internal Medicine
JF  - American Journal of Internal Medicine
JO  - American Journal of Internal Medicine
SP  - 141
EP  - 146
PB  - Science Publishing Group
SN  - 2330-4324
UR  - https://doi.org/10.11648/j.ajim.20190706.11
AB  - In response to the case of a patient with mesenteric panniculitis (MP) and proliferative disease, we reviewed the literature on their possible association and associations with other neoplasms. MP is a non-specific chronic inflammation of the mesenteric fat, with low prevalence and unknown etiology; patients may be asymptomatic or present predominantly gastrointestinal complaints. The disease can be either primary or secondary to other pathologies, including neoplastic ones. Diagnosis is made via computed tomography (CT) and confirmed by biopsy. Currently, there is no established treatment for MP. The literature contains series of variable sample sizes, case reports, reviews of other published studies, and some series after a 5-year follow-up. Papers tend to be relatively consistent when it comes to prevalence data and clinical manifestations. However, there is still controversy regarding the role that secondary MP could play in a paraneoplastic picture. From the diagnostic point of view, the incorporation and use of positron emission tomography (PET), together with CT, has been helpful for the approach and the diagnostic focus in this field. Nevertheless, its usage and the discrimination cut point between inflammatory pathology and tumor pathology (maximum standard uptake value: SUVmax) are not clearly defined in neoplastic cases.
VL  - 7
IS  - 6
ER  -

Copy | Download

Author Information

Mónica García-Fernández

Faculty of Medicine, Miguel Hernández University, Elche, Spain
María Dolores Jover-Ríos

Department of Internal Medicine, Hospital La Vega Baja of Orihuela, Alicante, Spain
Pedro Esteve-Atiénzar

Department of Internal Medicine, University Hospital of San Juan, Alicante, Spain
Juan Méndez-Mora

Department of English, Marist Brothers High School, Alicante, Spain
Alex Méndez-Jover

Department of English, Marist Brothers High School, Alicante, Spain
Sonia Cascant-Pérez

Primary Medicine, Hospital Francesc Borgia of Gandía, Valencia, Spain
Francisco Caparrós-Hernández

Department of English, Marist Brothers High School, Alicante, Spain
Carmen Seguí-Pérez

Department of English, Marist Brothers High School, Alicante, Spain
Marc Seguí-Pérez

Department of English, Marist Brothers High School, Alicante, Spain
Lidia Ramírez-Utrero

Primary Medicine, University Hospital of San Juan, Alicante, Spain
Carles García-Cervera

Department of Internal Medicine, University Hospital of San Juan, Alicante, Spain
Juan Manuel Núñez-Cruz
David Bonet-Tur

Department of Internal Medicine, University Hospital of San Juan, Alicante, Spain
Sara Bañón-Escandell
Pablo Roig-Rico

Department of Internal Medicine, University Hospital of San Juan, Alicante, Spain
Jorge Peris-García

Department of Internal Medicine, University Hospital of San Juan, Alicante, Spain
Asunción Pérez-Fullana

Department of English, Marist Brothers High School, Alicante, Spain
José Miguel Seguí-Ripoll

Department of Internal Medicine, University Hospital of San Juan, Alicante, Spain

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Mónica García-Fernández, María Dolores Jover-Ríos, Pedro Esteve-Atiénzar, Juan Méndez-Mora, Alex Méndez-Jover, et al. (2019). Secondary Mesenteric Panniculitis as a Paraneoplastic Syndrome: An Updated Review. American Journal of Internal Medicine, 7(6), 141-146. https://doi.org/10.11648/j.ajim.20190706.11

Copy | Download

ACS Style

Mónica García-Fernández; María Dolores Jover-Ríos; Pedro Esteve-Atiénzar; Juan Méndez-Mora; Alex Méndez-Jover, et al. Secondary Mesenteric Panniculitis as a Paraneoplastic Syndrome: An Updated Review. Am. J. Intern. Med. 2019, 7(6), 141-146. doi: 10.11648/j.ajim.20190706.11

Copy | Download

AMA Style

Mónica García-Fernández, María Dolores Jover-Ríos, Pedro Esteve-Atiénzar, Juan Méndez-Mora, Alex Méndez-Jover, et al. Secondary Mesenteric Panniculitis as a Paraneoplastic Syndrome: An Updated Review. Am J Intern Med. 2019;7(6):141-146. doi: 10.11648/j.ajim.20190706.11

Copy | Download

@article{10.11648/j.ajim.20190706.11,
  author = {Mónica García-Fernández and María Dolores Jover-Ríos and Pedro Esteve-Atiénzar and Juan Méndez-Mora and Alex Méndez-Jover and Sonia Cascant-Pérez and Francisco Caparrós-Hernández and Carmen Seguí-Pérez and Marc Seguí-Pérez and Lidia Ramírez-Utrero and Carles García-Cervera and Juan Manuel Núñez-Cruz and David Bonet-Tur and Sara Bañón-Escandell and Pablo Roig-Rico and Jorge Peris-García and Asunción Pérez-Fullana and José Miguel Seguí-Ripoll},
  title = {Secondary Mesenteric Panniculitis as a Paraneoplastic Syndrome: An Updated Review},
  journal = {American Journal of Internal Medicine},
  volume = {7},
  number = {6},
  pages = {141-146},
  doi = {10.11648/j.ajim.20190706.11},
  url = {https://doi.org/10.11648/j.ajim.20190706.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20190706.11},
  abstract = {In response to the case of a patient with mesenteric panniculitis (MP) and proliferative disease, we reviewed the literature on their possible association and associations with other neoplasms. MP is a non-specific chronic inflammation of the mesenteric fat, with low prevalence and unknown etiology; patients may be asymptomatic or present predominantly gastrointestinal complaints. The disease can be either primary or secondary to other pathologies, including neoplastic ones. Diagnosis is made via computed tomography (CT) and confirmed by biopsy. Currently, there is no established treatment for MP. The literature contains series of variable sample sizes, case reports, reviews of other published studies, and some series after a 5-year follow-up. Papers tend to be relatively consistent when it comes to prevalence data and clinical manifestations. However, there is still controversy regarding the role that secondary MP could play in a paraneoplastic picture. From the diagnostic point of view, the incorporation and use of positron emission tomography (PET), together with CT, has been helpful for the approach and the diagnostic focus in this field. Nevertheless, its usage and the discrimination cut point between inflammatory pathology and tumor pathology (maximum standard uptake value: SUVmax) are not clearly defined in neoplastic cases.},
 year = {2019}
}

Copy | Download

TY  - JOUR
T1  - Secondary Mesenteric Panniculitis as a Paraneoplastic Syndrome: An Updated Review
AU  - Mónica García-Fernández
AU  - María Dolores Jover-Ríos
AU  - Pedro Esteve-Atiénzar
AU  - Juan Méndez-Mora
AU  - Alex Méndez-Jover
AU  - Sonia Cascant-Pérez
AU  - Francisco Caparrós-Hernández
AU  - Carmen Seguí-Pérez
AU  - Marc Seguí-Pérez
AU  - Lidia Ramírez-Utrero
AU  - Carles García-Cervera
AU  - Juan Manuel Núñez-Cruz
AU  - David Bonet-Tur
AU  - Sara Bañón-Escandell
AU  - Pablo Roig-Rico
AU  - Jorge Peris-García
AU  - Asunción Pérez-Fullana
AU  - José Miguel Seguí-Ripoll
Y1  - 2019/10/24
PY  - 2019
N1  - https://doi.org/10.11648/j.ajim.20190706.11
DO  - 10.11648/j.ajim.20190706.11
T2  - American Journal of Internal Medicine
JF  - American Journal of Internal Medicine
JO  - American Journal of Internal Medicine
SP  - 141
EP  - 146
PB  - Science Publishing Group
SN  - 2330-4324
UR  - https://doi.org/10.11648/j.ajim.20190706.11
AB  - In response to the case of a patient with mesenteric panniculitis (MP) and proliferative disease, we reviewed the literature on their possible association and associations with other neoplasms. MP is a non-specific chronic inflammation of the mesenteric fat, with low prevalence and unknown etiology; patients may be asymptomatic or present predominantly gastrointestinal complaints. The disease can be either primary or secondary to other pathologies, including neoplastic ones. Diagnosis is made via computed tomography (CT) and confirmed by biopsy. Currently, there is no established treatment for MP. The literature contains series of variable sample sizes, case reports, reviews of other published studies, and some series after a 5-year follow-up. Papers tend to be relatively consistent when it comes to prevalence data and clinical manifestations. However, there is still controversy regarding the role that secondary MP could play in a paraneoplastic picture. From the diagnostic point of view, the incorporation and use of positron emission tomography (PET), together with CT, has been helpful for the approach and the diagnostic focus in this field. Nevertheless, its usage and the discrimination cut point between inflammatory pathology and tumor pathology (maximum standard uptake value: SUVmax) are not clearly defined in neoplastic cases.
VL  - 7
IS  - 6
ER  -

Copy | Download